Bristol Myers Squibb - 53 Year Stock Price History | BMY

Historical daily share price chart and data for Bristol Myers Squibb since 1972 adjusted for splits and dividends. The latest closing stock price for Bristol Myers Squibb as of July 03, 2025 is 46.92.
  • The all-time high Bristol Myers Squibb stock closing price was 72.96 on December 02, 2022.
  • The Bristol Myers Squibb 52-week high stock price is 63.33, which is 35% above the current share price.
  • The Bristol Myers Squibb 52-week low stock price is 39.50, which is 15.8% below the current share price.
  • The average Bristol Myers Squibb stock price for the last 52 weeks is 52.61.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bristol Myers Squibb Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 53.1428 55.5677 62.4333 44.1200 46.9200 -15.22%
2024 47.6684 49.1398 58.6499 38.1833 55.3426 15.81%
2023 57.5896 64.9856 67.5573 45.1534 47.7893 -26.14%
2022 64.7896 53.9742 72.9626 53.9742 64.7068 18.98%
2021 54.3034 52.3079 59.9663 46.7782 54.3841 2.88%
2020 50.7007 52.3159 55.6940 38.3242 52.8618 0.41%
2019 40.6504 41.5710 52.6462 34.7861 52.6462 27.74%
2018 45.3367 47.3391 53.6108 38.6611 41.2142 -12.90%
2017 44.0223 44.6887 50.4585 35.4271 47.3159 7.71%
2016 47.0497 49.4811 57.3110 37.0063 43.9295 -13.49%
2015 46.9633 42.9272 51.9132 41.8039 50.7803 19.26%
2014 37.0414 36.6754 43.9448 32.9185 42.5809 14.18%
2013 30.2389 22.2623 37.5224 22.2623 37.2928 69.96%
2012 22.0844 22.6614 24.0955 20.7439 21.9424 -3.80%
2011 18.4419 16.4208 22.8427 15.6207 22.8103 39.44%
2010 15.5702 15.2713 17.0571 13.5309 16.3590 8.74%
2009 12.5273 13.4574 15.2764 9.8676 15.0448 14.82%
2008 11.7664 13.9004 14.4058 9.5953 13.1024 -6.03%
2007 14.9364 13.4784 16.7351 13.3353 13.9429 4.79%
2006 11.9897 11.2223 13.3050 10.1161 13.3050 19.90%
2005 11.4954 11.7352 12.4969 10.1551 11.0968 -6.14%
2004 11.4037 13.0800 13.6549 10.2612 11.8228 -7.24%
2003 10.9637 10.2452 12.7458 9.0088 12.7458 29.14%
2002 12.7910 20.7903 20.9742 8.5568 9.8700 -52.40%
2001 22.4510 27.1572 27.1572 19.9239 20.7371 -26.16%
2000 21.9612 24.0762 28.0830 16.3203 28.0830 17.10%
1999 25.3342 24.0371 29.1203 21.3228 23.9828 -2.79%
1998 19.9226 17.2489 24.6708 16.3717 24.6708 43.03%
1997 13.7422 9.5641 17.7514 9.5641 17.2489 77.25%
1996 7.8819 7.0875 10.2596 6.7230 9.7314 36.90%
1995 5.6156 4.6691 7.1288 4.6491 7.1082 53.55%
1994 4.3241 4.3491 4.7852 3.8867 4.6291 6.47%
1993 4.2790 4.7638 4.7638 3.7666 4.3479 -9.22%
1992 5.0129 6.0666 6.1010 4.3621 4.7893 -21.05%
1991 5.3477 4.4339 6.0666 4.0845 6.0666 36.06%
1990 3.8418 3.6508 4.4664 3.2665 4.4589 24.31%
1989 3.1030 2.7280 3.6229 2.7049 3.5868 28.94%
1988 2.5537 2.5522 2.7970 2.2946 2.7818 14.36%
1987 2.7589 2.4154 3.1490 2.1330 2.4324 2.84%
1986 2.1038 1.7282 2.4723 1.5869 2.3653 35.83%
1985 1.5115 1.3049 1.7647 1.2667 1.7414 30.58%
1984 1.1576 1.0620 1.3336 1.0281 1.3336 28.17%
1983 0.9395 0.8004 1.1645 0.7526 1.0405 30.54%
1982 0.6958 0.6085 0.8682 0.5897 0.7971 31.21%
1981 0.5889 0.5634 0.6603 0.5095 0.6075 9.16%
1980 0.4439 0.3893 0.5675 0.3291 0.5565 40.53%
1979 0.3605 0.3658 0.4014 0.3278 0.3960 7.87%
1978 0.3384 0.3305 0.3977 0.2797 0.3671 10.24%
1977 0.3161 0.3256 0.3499 0.2790 0.3330 1.34%
1976 0.3448 0.3236 0.3913 0.2944 0.3286 2.08%
1975 0.2859 0.2329 0.3419 0.2147 0.3219 41.00%
1974 0.2071 0.2059 0.2491 0.1429 0.2283 11.80%
1973 0.2649 0.2935 0.3059 0.1924 0.2042 -30.94%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $95.486B $48.300B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $215.386B 16.08
Amgen (AMGN) United States $160.365B 14.37
Gilead Sciences (GILD) United States $139.009B 14.44
Vertex Pharmaceuticals (VRTX) United States $118.029B 0.00
GSK (GSK) United Kingdom $78.168B 9.36
CSL (CSLLY) Australia $77.435B 0.00
Regeneron Pharmaceuticals (REGN) United States $59.096B 14.34
Alnylam Pharmaceuticals (ALNY) United States $43.277B 0.00
Argenex SE (ARGX) Netherlands $33.185B 90.58
BioNTech SE (BNTX) Germany $26.443B 0.00
Royalty Pharma (RPRX) United States $20.449B 8.64
Biogen (BIIB) United States $19.469B 8.40
Insmed (INSM) United States $18.554B 0.00
Illumina (ILMN) United States $15.957B 30.27
Incyte (INCY) United States $13.250B 100.66
Genmab (GNMSF) Denmark $13.116B 13.41
Genmab (GMAB) Denmark $13.017B 14.60
Exelixis (EXEL) United States $12.585B 21.37
Moderna (MRNA) United States $11.792B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $11.368B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.027B 17.91
QIAGEN (QGEN) Netherlands $10.746B 20.91
Ascendis Pharma (ASND) Denmark $10.648B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
Exact Sciences (EXAS) United States $10.066B 0.00
Bio-Techne Corp (TECH) United States $8.331B 31.08
Blueprint Medicines (BPMC) United States $8.289B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.792B 0.00
Roivant Sciences (ROIV) United Kingdom $7.471B 0.00
Repligen (RGEN) United States $7.162B 80.17
Revolution Medicines (RVMD) United States $7.054B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Halozyme Therapeutics (HALO) United States $6.654B 12.74
Jazz Pharmaceuticals (JAZZ) Ireland $6.623B 6.50
Legend Biotech (LEGN) United States $6.549B 0.00
Guardant Health (GH) United States $6.256B 0.00
TG Therapeutics (TGTX) United States $5.829B 153.00
Nuvalent (NUVL) United States $5.779B 0.00
Telix Pharmaceuticals (TLX) Australia $5.438B 0.00
Anbio Biotechnology (NNNN) Germany $5.323B 0.00
Axsome Therapeutics (AXSM) United States $5.191B 0.00
Alkermes (ALKS) Ireland $4.757B 12.77
CRISPR Therapeutics AG (CRSP) Switzerland $4.506B 0.00
ADMA Biologics Inc (ADMA) United States $4.364B 32.64
Vaxcyte (PCVX) United States $4.289B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.184B 0.00
Cytokinetics (CYTK) United States $4.139B 0.00
Krystal Biotech (KRYS) United States $4.135B 31.87
Akero Therapeutics (AKRO) United States $4.127B 0.00
Zealand Pharma (ZLDPF) Denmark $4.102B 0.00
Zai Lab (ZLAB) China $4.043B 0.00
PTC Therapeutics (PTCT) United States $3.889B 6.77
Ultragenyx Pharmaceutical (RARE) United States $3.773B 0.00
Ascentage Pharma Group - (AAPG) China $3.733B 0.00
Merus (MRUS) Netherlands $3.725B 0.00
Arcellx (ACLX) United States $3.701B 0.00
Avidity Biosciences (RNA) United States $3.516B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.506B 30.81
Scholar Rock Holding (SRRK) United States $3.417B 0.00
Viking Therapeutics (VKTX) United States $3.166B 0.00
Protagonist Therapeutics (PTGX) United States $3.164B 68.07
MoonLake Immunotherapeutics (MLTX) Switzerland $3.130B 0.00
Metsera (MTSR) United States $3.094B 0.00
Kymera Therapeutics (KYMR) United States $2.917B 0.00
Immunovant (IMVT) United States $2.897B 0.00
Alvotech (ALVO) Luxembourg $2.771B 15.85
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.756B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.552B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.492B 0.00
ImmunityBio (IBRX) United States $2.401B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.319B 0.00
Apellis Pharmaceuticals (APLS) United States $2.295B 0.00
Twist Bioscience (TWST) United States $2.287B 0.00
Ligand Pharmaceuticals (LGND) United States $2.211B 0.00
Apogee Therapeutics (APGE) United States $2.185B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.142B 0.00
Denali Therapeutics (DNLI) United States $2.134B 0.00
Vericel (VCEL) United States $2.101B 1391.33
Bavarian Nordic (BVNRY) Denmark $2.091B 11.05
Agios Pharmaceuticals (AGIO) United States $2.089B 0.00
CG Oncology (CGON) United States $2.050B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.034B 0.00
Beam Therapeutics (BEAM) United States $2.012B 0.00
NovoCure (NVCR) Jersey $1.974B 0.00
IDEAYA Biosciences (IDYA) United States $1.936B 0.00
Disc Medicine (IRON) United States $1.896B 0.00
Belite Bio (BLTE) United States $1.893B 0.00
Amicus Therapeutics (FOLD) United States $1.878B 203.33
Harmony Biosciences Holdings (HRMY) United States $1.847B 12.27
Certara (CERT) United States $1.838B 34.33
Adaptive Biotechnologies (ADPT) United States $1.793B 0.00
Sarepta Therapeutics (SRPT) United States $1.793B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.729B 0.00
GRAIL (GRAL) United States $1.681B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.659B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.647B 0.00
Vera Therapeutics (VERA) United States $1.531B 0.00
Biohaven (BHVN) United States $1.494B 0.00
89BIO (ETNB) United States $1.483B 0.00
Celldex Therapeutics (CLDX) United States $1.460B 0.00
Janux Therapeutics (JANX) United States $1.447B 0.00
ANI Pharmaceuticals (ANIP) United States $1.414B 14.57
Edgewise Therapeutics (EWTX) United States $1.371B 0.00
Mesoblast (MESO) Australia $1.365B 0.00
Travere Therapeutics (TVTX) United States $1.333B 0.00
Viridian Therapeutics (VRDN) United States $1.279B 0.00
Dynavax Technologies (DVAX) United States $1.233B 73.36
CureVac (CVAC) Germany $1.223B 5.92
Structure Therapeutics (GPCR) United States $1.168B 0.00
AbCellera Biologics (ABCL) Canada $1.134B 0.00
Intellia Therapeutics (NTLA) United States $1.112B 0.00
Novavax (NVAX) United States $1.101B 2.57
MannKind (MNKD) United States $1.094B 22.50
WAVE Life Sciences (WVE) Singapore $1.081B 0.00
Pacira BioSciences (PCRX) United States $1.075B 10.23
Liquidia Technologies (LQDA) United States $1.042B 0.00
Niagen Bioscience (NAGE) United States $1.001B 141.22
Cidara Therapeutics (CDTX) United States $0.984B 0.00
BGM Group (BGM) China $0.975B 0.00
Pharvaris (PHVS) Netherlands $0.973B 0.00
NeoGenomics (NEO) United States $0.972B 0.00
Nurix Therapeutics (NRIX) United States $0.970B 0.00
Praxis Precision Medicines (PRAX) United States $0.963B 0.00
Spyre Therapeutics (SYRE) United States $0.950B 0.00
Mineralys Therapeutics (MLYS) United States $0.948B 0.00
MiMedx (MDXG) United States $0.936B 22.64
Sionna Therapeutics (SION) United States $0.935B 0.00
Anavex Life Sciences (AVXL) United States $0.921B 0.00
Oric Pharmaceuticals (ORIC) United States $0.920B 0.00
LENZ Therapeutics (LENZ) United States $0.916B 0.00
Geron (GERN) United States $0.911B 0.00
Zymeworks (ZYME) United States $0.909B 0.00
Arcus Biosciences (RCUS) United States $0.897B 0.00
Cogent Biosciences (COGT) United States $0.863B 0.00
Oculis Holding AG (OCS) Switzerland $0.830B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
UniQure (QURE) Netherlands $0.790B 0.00
CorMedix Inc (CRMD) United States $0.788B 52.82
GH Research (GHRS) Ireland $0.776B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.774B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
Immunome (IMNM) United States $0.769B 0.00
Gyre Therapeutics (GYRE) United States $0.762B 203.25
Vir Biotechnology (VIR) United States $0.748B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.745B 0.00
Replimune (REPL) United States $0.725B 0.00
Pharming Group (PHAR) Netherlands $0.720B 0.00
Sana Biotechnology (SANA) United States $0.719B 0.00
Nuvation Bio (NUVB) United States $0.711B 0.00
ArriVent BioPharma (AVBP) United States $0.711B 0.00
Trevi Therapeutics (TRVI) United States $0.698B 0.00
AnaptysBio (ANAB) United States $0.698B 0.00
Immatics (IMTX) Germany $0.694B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.689B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.669B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.631B 0.00
Stoke Therapeutics (STOK) United States $0.627B 14.53
Urogen Pharma (URGN) United States $0.626B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.623B 0.00
Arbutus Biopharma (ABUS) United States $0.621B 0.00
Tango Therapeutics (TNGX) United States $0.618B 0.00
Dianthus Therapeutics (DNTH) United States $0.606B 0.00
Jyong Biotech (MENS) Taiwan $0.604B 0.00
MeiraGTx Holdings (MGTX) United States $0.604B 0.00
Upstream Bio (UPB) United States $0.602B 0.00
Castle Biosciences (CSTL) United States $0.586B 39.80
Iovance Biotherapeutics (IOVA) United States $0.584B 0.00
Arvinas (ARVN) United States $0.580B 0.00
Sage Therapeutics (SAGE) United States $0.576B 0.00
Keros Therapeutics (KROS) United States $0.546B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.542B 0.00
Tyra Biosciences (TYRA) United States $0.531B 0.00
Opthea (OPT) Australia $0.525B 0.00
Celcuity (CELC) United States $0.522B 0.00
Myriad Genetics (MYGN) United States $0.516B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.515B 0.00
Kura Oncology (KURA) United States $0.507B 0.00
Septerna (SEPN) United States $0.507B 0.00
Abivax SA (ABVX) France $0.505B 0.00
Maze Therapeutics (MAZE) United States $0.504B 0.00
Bicara Therapeutics (BCAX) United States $0.492B 0.00
Precigen (PGEN) United States $0.478B 0.00
Cytek Biosciences (CTKB) United States $0.476B 0.00
ATyr Pharma (ATYR) United States $0.473B 0.00
Fortrea Holdings (FTRE) United States $0.472B 13.05
Cullinan Therapeutics (CGEM) United States $0.461B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.456B 0.00
Kamada (KMDA) Israel $0.453B 27.17
Oxford BioMedica (OXBDF) United Kingdom $0.448B 0.00
Rapport Therapeutics (RAPP) United States $0.439B 0.00
REGENXBIO (RGNX) United States $0.438B 0.00
PureTech Health (PRTC) United States $0.433B 0.00
Zenas BioPharma (ZBIO) United States $0.420B 0.00
Prime Medicine (PRME) United States $0.418B 0.00
MBX Biosciences (MBX) United States $0.417B 0.00
Rezolute (RZLT) United States $0.412B 0.00
Erasca (ERAS) United States $0.408B 0.00
Tectonic Therapeutic (TECX) United States $0.398B 0.00
Solid Biosciences (SLDB) United States $0.390B 0.00
ITeos Therapeutics (ITOS) United States $0.390B 0.00
Eton Pharmaceuticals (ETON) United States $0.388B 0.00
Compass Therapeutics (CMPX) United States $0.384B 0.00
Vigil Neuroscience (VIGL) United States $0.381B 0.00
Emergent Biosolutions (EBS) United States $0.379B 0.00
Citius Oncology (CTOR) United States $0.379B 0.00
Terns Pharmaceuticals (TERN) United States $0.377B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.374B 0.00
Fulcrum Therapeutics (FULC) United States $0.374B 0.00
Northwest Biotherapeutics (NWBO) United States $0.362B 0.00
Humacyte (HUMA) United States $0.354B 0.00
Absci (ABSI) United States $0.353B 0.00
Amarin (AMRN) Ireland $0.346B 0.00
Prothena (PRTA) Ireland $0.346B 0.00
Benitec Biopharma (BNTC) United States $0.346B 0.00
Aura Biosciences (AURA) United States $0.330B 0.00
Astria Therapeutics (ATXS) United States $0.328B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.326B 0.00
XOMA Royalty (XOMA) United States $0.323B 0.00
Atea Pharmaceuticals (AVIR) United States $0.320B 0.00
DBV Technologies S.A (DBVT) France $0.318B 0.00
Annexon (ANNX) United States $0.317B 0.00
Olema Pharmaceuticals (OLMA) United States $0.313B 0.00
Crescent Biopharma (CBIO) United States $0.311B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.310B 0.00
Aardvark Therapeutics (AARD) United States $0.302B 0.00
Abeona Therapeutics (ABEO) United States $0.301B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.300B 60.88
Lifecore Biomedical (LFCR) United States $0.298B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.293B 0.00
Cartesian Therapeutics (RNAC) United States $0.291B 0.00
Inventiva S.A (IVA) France $0.288B 0.00
Neurogene (NGNE) United States $0.287B 0.00
Foghorn Therapeutics (FHTX) United States $0.286B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.285B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.283B 0.00
Gossamer Bio (GOSS) United States $0.282B 0.00
Ocugen (OCGN) United States $0.279B 0.00
Alpha Teknova (TKNO) United States $0.278B 0.00
Entrada Therapeutics (TRDA) United States $0.274B 8.93
Corvus Pharmaceuticals (CRVS) United States $0.269B 0.00
Palvella Therapeutics (PVLA) United States $0.267B 0.00
Verastem (VSTM) United States $0.264B 0.00
Allogene Therapeutics (ALLO) United States $0.260B 0.00
Candel Therapeutics (CADL) United States $0.256B 0.00
Sagimet Biosciences (SGMT) United States $0.253B 0.00
Prima BioMed (IMMP) Australia $0.251B 0.00
Third Harmonic Bio (THRD) United States $0.245B 0.00
Cardiff Oncology (CRDF) United States $0.243B 0.00
Adherex Technologies (FENC) United States $0.243B 0.00
Vor Biopharma (VOR) $0.239B 0.00
MaxCyte (MXCT) United States $0.238B 0.00
Inhibrx Biosciences (INBX) United States $0.236B 0.14
Codexis (CDXS) United States $0.229B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.229B 0.00
Semper Paratus Acquisition (TVGN) United States $0.228B 0.00
Monopar Therapeutics (MNPR) United States $0.222B 0.00
SELLAS Life Sciences (SLS) United States $0.217B 0.00
Adocia (ADOCY) France $0.216B 0.00
Editas Medicine (EDIT) United States $0.215B 0.00
Design Therapeutics (DSGN) United States $0.214B 0.00
Tvardi Therapeutics (TVRD) United States $0.210B 0.00
ScPharmaceuticals (SCPH) United States $0.210B 0.00
Kodiak Sciences (KOD) United States $0.208B 0.00
AC Immune (ACIU) Switzerland $0.208B 0.00
CARGO Therapeutics (CRGX) United States $0.206B 0.00
CytomX Therapeutics (CTMX) United States $0.202B 5.21
Bright Minds Biosciences (DRUG) United States $0.200B 0.00
BioStem Technologies (BSEM) $0.200B 8.12
Y-mAbs Therapeutics (YMAB) United States $0.195B 0.00
EnGene Holdings (ENGN) Canada $0.194B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.194B 0.00
GENFIT S.A (GNFT) France $0.193B 0.00
Alumis (ALMS) United States $0.185B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.184B 0.00
Instil Bio (TIL) United States $0.180B 0.00
Puma Biotechnology (PBYI) United States $0.178B 4.65
Voyager Therapeutics (VYGR) United States $0.177B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.176B 0.00
I-Mab (IMAB) United States $0.176B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.169B 0.00
Innate Pharma S.A (IPHA) France $0.168B 0.00
Alpha Cognition (ACOG) Canada $0.168B 0.00
Agenus (AGEN) United States $0.166B 0.00
Spero Therapeutics (SPRO) United States $0.163B 0.00
Anika Therapeutics (ANIK) United States $0.161B 0.00
DiaMedica Therapeutics (DMAC) United States $0.161B 0.00
Nuvectis Pharma (NVCT) United States $0.158B 0.00
Compugen (CGEN) Israel $0.157B 0.00
BioAge Labs (BIOA) United States $0.153B 0.00
Molecular Partners AG (MOLN) Switzerland $0.152B 0.00
Alector (ALEC) United States $0.151B 0.00
Ventyx Biosciences (VTYX) United States $0.148B 0.00
Theratechnologies (THTX) Canada $0.147B 0.00
Black Diamond Therapeutics (BDTX) United States $0.147B 43.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.145B 0.00
Skye Bioscience (SKYE) United States $0.143B 0.00
23andMe Holding (MEHCQ) United States $0.135B 0.00
Greenwich LifeSciences (GLSI) United States $0.134B 0.00
Seer (SEER) United States $0.134B 0.00
Rapt Therapeutics (RAPT) United States $0.133B 0.00
Neumora Therapeutics (NMRA) United States $0.133B 0.00
Actuate Therapeutics (ACTU) United States $0.129B 0.00
Fate Therapeutics (FATE) United States $0.128B 0.00
Caribou Biosciences (CRBU) United States $0.127B 0.00
Elicio Therapeutics (ELTX) United States $0.127B 0.00
Nkarta (NKTX) United States $0.124B 0.00
Immuneering (IMRX) United States $0.124B 0.00
Sangamo Therapeutics (SGMO) United States $0.123B 0.00
Kyverna Therapeutics (KYTX) United States $0.121B 0.00
BioHarvest Sciences (BHST) Canada $0.113B 0.00
Genelux (GNLX) United States $0.112B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.111B 0.00
TuHURA Biosciences (HURA) United States $0.108B 0.00
C4 Therapeutics (CCCC) United States $0.105B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.104B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.104B 0.00
Seres Therapeutics (MCRB) United States $0.104B 0.00
Nautilus Biotechnology (NAUT) United States $0.103B 0.00
HilleVax (HLVX) United States $0.103B 0.00
Jasper Therapeutics (JSPR) United States $0.102B 0.00
Contineum Therapeutics (CTNM) United States $0.100B 0.00
Coya Therapeutics (COYA) United States $0.100B 0.00
Tenaya Therapeutics (TNYA) United States $0.100B 0.00
IO Biotech (IOBT) Denmark $0.098B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.098B 0.00
XBiotech (XBIT) United States $0.097B 0.00
OKYO Pharma (OKYO) $0.094B 0.00
Coherus Oncology (CHRS) United States $0.094B 0.00
Whitehawk Therapeutics (WHWK) United States $0.094B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.091B 0.00
Forte Biosciences (FBRX) United States $0.090B 0.00
BeyondSpring (BYSI) United States $0.090B 0.00
Invivyd (IVVD) United States $0.088B 0.00
Cellectis S.A (CLLS) France $0.088B 0.00
Adagene (ADAG) China $0.087B 0.00
Oncolytics Biotech (ONCY) Canada $0.087B 0.00
Climb Bio (CLYM) United States $0.087B 0.00
Elutia (ELUT) United States $0.086B 0.00
Entera Bio (ENTX) Israel $0.086B 0.00
TScan Therapeutics (TCRX) United States $0.085B 0.00
EXoZymes (EXOZ) United States $0.083B 0.00
Cabaletta Bio (CABA) United States $0.083B 0.00
IGM Biosciences (IGMS) United States $0.081B 0.00
TELA Bio (TELA) United States $0.081B 0.00
Pliant Therapeutics (PLRX) United States $0.077B 0.00
Zura Bio (ZURA) United States $0.077B 0.00
Quince Therapeutics (QNCX) United States $0.073B 0.00
Immix Biopharma (IMMX) United States $0.071B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.070B 0.00
Immunic (IMUX) United States $0.070B 0.00
Genenta Science S.p.A (GNTA) Italy $0.070B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.069B 0.00
Akoya Biosciences (AKYA) United States $0.068B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.066B 0.00
Connect Biopharma Holdings (CNTB) United States $0.065B 0.00
Sutro Biopharma (STRO) United States $0.064B 0.00
Ikena Oncology (IKNA) United States $0.064B 0.00
Alto Neuroscience (ANRO) United States $0.064B 0.00
Clearside Biomedical (CLSD) United States $0.063B 0.00
Biomea Fusion (BMEA) United States $0.062B 0.00
Repare Therapeutics (RPTX) Canada $0.062B 0.00
MediciNova (MNOV) United States $0.061B 0.00
PDS Biotechnology (PDSB) United States $0.061B 0.00
Oncobiologics (OTLK) United States $0.060B 0.00
INmune Bio (INMB) United States $0.060B 0.00
Opus Genetics (IRD) United States $0.060B 0.00
VistaGen Therapeutics (VTGN) United States $0.058B 0.00
Earth Science Tech (ETST) United States $0.057B 0.00
Senti Biosciences (SNTI) United States $0.057B 0.00
Fortress Biotech (FBIO) United States $0.056B 0.00
Adlai Nortye (ANL) Cayman Islands $0.055B 0.00
InflaRx (IFRX) Germany $0.054B 0.00
ABVC BioPharma (ABVC) United States $0.053B 0.00
Cue Biopharma (CUE) United States $0.052B 0.00
Atara Biotherapeutics (ATRA) United States $0.050B 0.00
Adicet Bio (ACET) United States $0.050B 0.00
RenovoRx (RNXT) United States $0.050B 0.00
Renovaro (RENB) United States $0.050B 0.00
Quantum Biopharma (QNTM) Canada $0.050B 0.00
CervoMed (CRVO) United States $0.049B 0.00
Inovio Pharmaceuticals (INO) United States $0.049B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
Precision BioSciences (DTIL) United States $0.048B 0.00
Werewolf Therapeutics (HOWL) United States $0.048B 0.00
Aligos Therapeutics (ALGS) United States $0.048B 0.00
Adverum Biotechnologies (ADVM) United States $0.048B 0.00
Celularity (CELU) United States $0.047B 0.00
Kalaris Therapeutics (KLRS) United States $0.047B 0.00
Annovis Bio (ANVS) United States $0.046B 0.00
Medicus Pharma (MDCX) United States $0.046B 0.00
Applied Therapeutics (APLT) United States $0.045B 0.00
Pluri (PLUR) Israel $0.045B 0.00
Scilex Holding (SCLX) United States $0.044B 0.00
Grace Therapeutics (GRCE) Canada $0.043B 0.00
Exicure (XCUR) United States $0.043B 0.00
PepGen (PEPG) United States $0.040B 0.00
Shattuck Labs (STTK) United States $0.040B 0.00
Artiva Biotherapeutics (ARTV) United States $0.039B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.038B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.037B 0.00
Alterity Therapeutics - (ATHE) Australia $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Mersana Therapeutics (MRSN) United States $0.036B 0.00
Lantern Pharma (LTRN) United States $0.035B 0.00
Clene (CLNN) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.035B 0.00
Kezar Life Sciences (KZR) United States $0.033B 0.00
Rein Therapeutics (RNTX) United States $0.033B 0.00
KALA BIO (KALA) United States $0.033B 0.00
OnKure Therapeutics (OKUR) United States $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.031B 0.00
Radiopharm Theranostics - (RADX) Australia $0.031B 0.00
Rani Therapeutics Holdings (RANI) United States $0.031B 0.00
CAMP4 Therapeutics (CAMP) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Passage Bio (PASG) United States $0.029B 0.00
Dyadic (DYAI) United States $0.028B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.026B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.026B 0.00
Cognition Therapeutics (CGTX) United States $0.025B 0.00
ALX Oncology Holdings (ALXO) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Ovid Therapeutics (OVID) United States $0.024B 0.00
Boundless Bio (BOLD) United States $0.024B 0.00
Femasys (FEMY) United States $0.024B 0.00
FibroBiologics (FBLG) United States $0.023B 0.00
Generation Bio (GBIO) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
CalciMedica (CALC) United States $0.023B 0.00
BioAtla (BCAB) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Dare Bioscience (DARE) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
BRIACELL THERAP (BCTX) Canada $0.020B 0.00
Longeveron (LGVN) United States $0.020B 0.00
Curis (CRIS) United States $0.019B 0.00
Cingulate (CING) United States $0.018B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.018B 0.00
Q32 Bio (QTTB) United States $0.018B 0.00
Gelteq (GELS) Australia $0.016B 0.00
Hoth Therapeutics (HOTH) United States $0.016B 0.00
SAB Biotherapeutics (SABS) United States $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.016B 0.00
Beyond Air (XAIR) United States $0.015B 0.00
Allarity Therapeutics (ALLR) United States $0.015B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Advanced Biomed (ADVB) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.014B 0.00
Promis Neurosciences (PMN) Canada $0.014B 0.00
Imunon (IMNN) United States $0.014B 0.00
Rallybio (RLYB) United States $0.014B 0.00
Synlogic (SYBX) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Athira Pharma (ATHA) United States $0.013B 0.00
MetaVia (MTVA) United States $0.013B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.012B 0.00
IBio (IBIO) United States $0.012B 0.00
NextCure (NXTC) United States $0.012B 0.00
Leap Therapeutics (LPTX) United States $0.012B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Equillium (EQ) United States $0.011B 0.00
Abpro Holdings (ABP) United States $0.011B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
X4 Pharmaceuticals (XFOR) United States $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
Jade Biosciences (JBIO) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
GeoVax Labs (GOVX) United States $0.008B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Novogen (KZIA) Australia $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Biofrontera (BFRI) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.006B 0.00
Artelo Biosciences (ARTL) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
UNITY Biotechnology (UBX) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Mainz Biomed (MYNZ) Germany $0.005B 0.00
Moleculin Biotech (MBRX) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00